LG Life Sciences

LG Life Sciences is a leading pharmaceutical manufacturing company dedicated to advancing healthcare solutions through innovative research and development. Since beginning its research in genetic engineering in 1981, LG Life Sciences has consistently invested in the life sciences, leading to world-class technology and product capabilities. The company focuses its resources and expertise on pharmaceuticals, animal health, and specialty chemicals.

LG Life Sciences has successfully developed and commercialized a diverse range of pharmaceuticals, including innovative treatments and vaccines. A significant milestone was achieved with the FDA approval of its next-generation quinolone antibiotic (FACTIVE®) in the United States in 2003. LG Life Sciences is committed to expanding its strategic alliances and enhancing its ability to identify promising drug candidates, accelerating the development of new medicines and focusing marketing competencies on advanced markets.

With a vision to become a top-tier life sciences company with world-class new drugs, LG Life Sciences is poised for continued growth and innovation. LG Life Sciences remains committed to leading in life sciences and biotechnology, delivering value-added products and services that address critical healthcare needs. We invite the manager of LG Life Sciences to create a customized and exclusive company showcase and product listing on our platform.